Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.
Key questions (and answers) about the historic approval of a CRISPR-based medicine
History just happened. For the first time, a regulator has cleared a treatment using CRISPR, the gene-editing technology, for patients. The regulator is the United
November 16, 2023